{Reference Type}: Journal Article
{Title}: Potential of Targeting TDO2 as the Lung Adenocarcinoma Treatment.
{Author}: Jin E;Yin Z;Zheng X;Yan C;Xu K;Eunice FY;Gao Y;
{Journal}: J Proteome Res
{Volume}: 23
{Issue}: 4
{Year}: 2024 Apr 5
{Factor}: 5.37
{DOI}: 10.1021/acs.jproteome.3c00746
{Abstract}: Tryptophan catabolism plays an important role in the metabolic reconnection in cancer cells to support special demands of tumor initiation and progression. The catabolic product of the tryptophan pathway, kynurenine, has the capability of suppressing the immune reactions of tumor cells. In this study, we conducted internal and external cohort studies to reveal the importance of tryptophan 2,3-dioxygenase (TDO) for lung adenocarcinoma (LUAD). Our study further demonstrated that the TDO2 expression was associated with the proliferation, survival, and invasion of LUAD cells, and targeting TDO2 for LUAD tumors could be a potential therapeutic strategy.